OTCM
NWVCF
Market cap15mUSD
Oct 08, Last price
0.13USD
1D
-4.21%
1Q
-30.56%
Name
Enwave Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
EnWave Corporation, based in Delta, Canada, is an innovator in advanced vacuum-microwave dehydration technology. The company develops, manufactures, markets, licenses, installs, and services its specialized machinery for industries focused on food, cannabis, and biomaterial processing throughout Canada and the United States. Among its offerings are proprietary Radiant Energy Vacuum (REV) dehydration platforms, notably nutraREV and quantaREV. These systems are designed to efficiently remove moisture from a broad spectrum of products, including fruits, vegetables, herbs, dairy items, ready-to-eat meals, instant baked goods, cannabis products, nutraceuticals, pharmaceuticals, and various meats and seafood. EnWave further provides specialized REV solutions for the pharmaceutical sector, such as powderREV, and its freezeREV platform, tailored for dehydrating biomaterial and pharmaceutical compounds. In addition to its technological solutions, EnWave manufactures and sells a range of flavored cheese snacks, featuring varieties like cheddar, gouda, bacon cheddar, parmesan garlic, black pepper, white cheddar, and pepper jack. The company distributes its products through a diverse set of channels, including direct client engagements, collaborations with brokers, distributors, and retailers, its own online store at mooncheese.com, and through Amazon.com. EnWave Corporation was established in 1999.
Key people
Daniel Stephen Henriques
Chief Financial Officer · since 2015
Executive Chairman of the Board · since 2014
Independent Director · since 2014
Stewart John Ritchie
Independent Director · since 2013
Stephen R. Sanford
Independent Director · since 2019
Headquarters & legal address
1000 Cathedral Place
Vancouver, BC V6C 3L2
CA
Vancouver, BC V6C 3L2
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||